PCV74 ONE-YEAR COST-EFFECTIVENESS OF CYTOCHROME P450 2C19 GENOTYPE-GUIDED ANTIPLATELET THERAPY IN PATIENTS WITH ACUTE CORONARY SYNDROMES IN THE UNITED KINGDOM
Abstract
Authors
SL Charland B Agatep D Malone E Stanek
SL Charland B Agatep D Malone E Stanek
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now